Biden Administration Set to Announce First Round of Drugs to Be Eligible for Medicare Negotiation by September 1
Today, Protect Our Care is kicking off a new series of videos showing what the Inflation Reduction Act’s measures to drive down drug prices means to real people across the nation. Before September 1, the Biden administration will announce the first round of drugs eligible for lower prices under the Medicare Drug Negotiation Program created by the Inflation Reduction Act. Thanks to President Biden and Democrats in Congress, millions of Americans will no longer have to choose between paying for food or rent and the medicines they need. Prescription drugs don’t work if people cannot afford to take them.
Today’s story features Bill, who cares for his 94-year-old mother-in-law. She takes 17 medications — including Januvia, which costs her $600 per month and, according to a Protect Our Care analysis, could be eligible for negotiation under the Inflation Reduction Act.
Right now, big drug companies are going to court to try to stop Medicare from negotiating lower drug prices for the American people. After spending hundreds of millions of dollars to stop Medicare negotiation, they are still fighting to protect their sky-high profits at the expense of seniors struggling to make ends meet.